艾力斯2024年年度及2025年一季度业绩点评:伏美替尼快速放量,经营表现持续向好
⚫ ⚫ ⚫ ⚫ ⚫ ⚫ 35.58 49.60 60.02 72.10 76.29 39.40 21.01 20.13 14.30 18.20 21.88 26.42 121.97 27.25 20.23 20.75 95.97 96.04 96.07 96.08 3.18 4.04 4.86 5.87 28.05 22.04 18.33 15.18 7.59 5.69 4.34 3.38 11.27 8.09 6.68 5.56 41.80 60.53 83.80 124.60 35.58 49.60 60.02 72.10 5.87 17.96 38.55 76.17 1.43 1.96 2.36 2.82 3.89 6.20 7.50 9.01 0.49 0.50 0.54 0.65 0.05 0.28 0.33 0.40 14.13 20.34 24.37 29.05 0.96 2.36 3.07 3.95 1.65 3.47 4.20 5.05 0.31 3.00 3.61 4.31 -0.61 -0.12 -0.36 -0.77 30.72 30.75 30.75 30.75 0.00 0.00 0.00 0.00 17.36 18.00 17.73 17.45 0.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.17 0.18 0.19 5.10 4.90 4.66 4.40 16.35 18.38 22.10 26.68 0.65 0.63 0.61 0.59 0.00 0.00 0.00 0.00 11.61 12.47 12.46 12.45 0.16 0.00 0.00 0.00 59.16 78.54 101.54 142.05 16.19 18.38 22.10 26.68 6.01 7.86 8.99 23.08 1.89 0.18 0.22 0.27 0.00 0.00 0.00 0.00 14.30 18.20 21.88 26.42 0.82 3.82 4.59 17.26 0.00 0.00 0.00 0.00 5.19 4.05 4.40 5.82 14.30 18.20 21.88 26.42 0.33 0.21 0.21 0.21 15.77 18.72 22.21 26.40 0.00 0.00 0.00 0.00 3.18 4.04 4.86 5.87 0.33 0.21 0.21 0.21 6.33 8.08 9.20 23.30 0.00 0.00 0.00 0.00 76.29%39.40%21.01%20.13%52.83 70.46 92.33 118.75 148.57%12.43%20.23%20.75%59.16 78.54 101.54 142.05 121.97%27.25%20.23%20.75%95.97% 96.04% 96.07% 96.08% 40.19%36.69%36.45%36.64%15.66 13.60 20.61 37.64 27.07%25.82%23.69%22.25%14.30 18.20 21.88 26.42 25.70%25.65%23.30%21.60%0.40 0.46 0.47 0.48 10.70%10.29%9.06%16.40%-0.44 0.00 0.00 0.00 -11.09%-25.45%-41.72%-64.13%-0.08 -0.17 -0.18 -0.19 6.96 7.70 9.33 5.40 1.63 -4.77 -1.56 10.93 6.23 6.62 8.23 4.90 -0.15 -0.11 0.00 0.00 0.69 0.72 0.67 0.59 -18.35 -0.96 -0.02 -0.01 10.96 9.83 8.76 8.73 -2.70 -0.40 -0.20 -0.20 2.12 0.85 0.56 0.26 0.00 0.00 0.00 0.00 3.18 4.04 4.86 5.87 -15.65 -0.55 0.18 0.19 3.48 3.02 4.58 8.36 -2.95 -0.55 0.00 0.00 11.74 15.66 20.52 26.39 0.00 0.00 0.00 0.00 28.05 22.04 18.33 15.18 0.00 0.00 0.00 0.00 7.59 5.69 4.34 3.38 -2.95 -0.55 0.00 0.00 16.72 20.46 16.32 12.31 -5.61 12.09 20.59 37.63 11.27 8.09 6.68 5.56
艾力斯2024年年度及2025年一季度业绩点评:伏美替尼快速放量,经营表现持续向好,点击即可下载。报告格式为PDF,大小2.43M,页数12页,欢迎下载。

